Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Country / region: United States Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20035
20043
20057
20063
20072
20088
20091
20107
20114
20122
20136
20146
20159
20169
20179
20185
20194
20209
20217
20227
20236
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated31
Recruiting17
Active, not recruiting14
Withdrawn6
Unknown status4
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center10
National Cancer Institute (NCI)10
Mayo Clinic6
Northwestern University6
University of Washington5
Hoffmann-La Roche4
Incyte Corporation4
Celgene3
Genmab3
M.D. Anderson Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse145
Lymphoma, Follicular78
Lymphoma, Non-Hodgkin72
Lymphoma, Mantle-Cell68
Lymphoma59
Leukemia, Lymphocytic, Chronic, B-Cell56
Lymphoma, B-Cell, Marginal Zone50
Burkitt Lymphoma48
Precursor Cell Lymphoblastic Leukemia-Lymphoma38
Hodgkin Disease37

Trials

Showing 1 to 25 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.